drugset / Trial / NCT04387136
Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.
Timeline
- Start
- 2020-10-14
- Primary completion
- 2021-02-04
- Completion
- 2021-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sufentanil | Other / unclassified | 30 ug | Other |
Indications
No indication recorded.